CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEM ...

Cohen encouraged researchers to look at biomarker patterns within racial minority groups with dementia, rather than only trying to compare diverse cohorts against white cohorts.

At closing of the transaction, JASMIN shall acquire Pierre Fabre's R&D Centre (including R&D Site and R&D activities) at Saint-Julien-en-Genevois, France, and JBIRSPL would also execute a Shareholders ...

Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration with Toray Industries, Inc. is Caprin-1, a novel cancer target discovered by Toray. The ...

23. Dahiya D, Mackin C, Nigam PS. Studies on bioactivities of Manuka and regional varieties of honey for their potential use ...

An increase in high-fat, high-fructose foods in people's diets has contributed to a dramatic increase in type 2 diabetes.

Understanding why newborns, but not adults, can regenerate the heart could lead to treatments that "reprogram" adult ...

Newborns with heart complications can rely on their newly developed immune systems to regenerate cardiac tissues, but adults aren't so lucky. After a heart attack, most adults struggle to regenerate ...

The American Council on Education & the Carnegie Foundation have released an updated classification of colleges, resulting in ...

Each UC campus now resides among the exclusive group of 187 accredited doctoral-granting universities in the United States ...

DALLAS ( SMU) – SMU has achieved Carnegie Research One (R1) classification, joining the ranks of the nation’s top public and ...

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...